Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Carcinoma Stage II”

527 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 527 results

Testing effectiveness (Phase 2)Study completedNCT00996333
What this trial is testing

Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)

Who this might be right for
Metastatic Pancreatic Cancer
Columbia University 46
Large-scale testing (Phase 3)UnknownNCT00268411
What this trial is testing

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 80
Testing effectiveness (Phase 2)UnknownNCT02863471
What this trial is testing

Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma

Who this might be right for
Adenocarcinomas of the Pancreas
University Hospital Tuebingen 16
Large-scale testing (Phase 3)UnknownNCT03959150
What this trial is testing

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 231
Testing effectiveness (Phase 2)Ended earlyNCT00967291
What this trial is testing

Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 21
Testing effectiveness (Phase 2)Study completedNCT01601808
What this trial is testing

Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
University of Liverpool 142
Testing effectiveness (Phase 2)UnknownNCT02329717
What this trial is testing

Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Phoenix Biotechnology, Inc 50
Early research (Phase 1)Study completedNCT00983268
What this trial is testing

Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPeriampullary Adenocarcinoma
Vanderbilt-Ingram Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Not applicableStudy completedNCT01846520
What this trial is testing

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Who this might be right for
Healthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more
City of Hope Medical Center 200
Early research (Phase 1)Ended earlyNCT00003434
What this trial is testing

Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University 8
Large-scale testing (Phase 3)Looking for participantsNCT03755739
What this trial is testing

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Who this might be right for
HepatocarcinomaLung CancerMelanoma+7 more
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)WithdrawnNCT02575508
What this trial is testing

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+14 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02023021
What this trial is testing

Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 80
Testing effectiveness (Phase 2)Study completedNCT02428270
What this trial is testing

GSK2256098 and Trametinib in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Study completedNCT00674973
What this trial is testing

A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 207
Testing effectiveness (Phase 2)Study completedNCT03861702
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Who this might be right for
Locally Advanced Pancreatic Carcinoma(LAPC)
Nelson Yee 28
Testing effectiveness (Phase 2)Study completedNCT00691054
What this trial is testing

Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
University of Miami 20
Testing effectiveness (Phase 2)Study completedNCT00004861
What this trial is testing

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Pfizer
Testing effectiveness (Phase 2)Study completedNCT01730222
What this trial is testing

A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 137
Load More Results